StonvexLoading…
StonvexStonvexStonvexCore line items from PRTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $262.99M | $249.56M | $953.01M | $705.88M | $464.44M |
Operating Income | Not available | $33.39M | $141.25M | $107.75M | $69.97M |
Net Income | Not available | $9.76M | $55.68M | $46.73M | $10.88M |
EPS (Diluted) | $0.27 | $0.12 | $0.68 | $0.58 | $0.24 |
Total Assets | Not available | $2.47B | $2.40B | $2.22B | $2.03B |
Total Liabilities | Not available | $2.55B | $2.49B | $2.33B | $2.17B |
Cash & Equivalents | Not available | $92.15M | $77.19M | $56.98M | $50.56M |
Free Cash Flow OCF − CapEx | Not available | $18.32M | $75.08M | $44.21M | $14.09M |
Shares Outstanding | Not available | 82.30M | 81.91M | 81.82M | 79.90M |